Invitae: David Sholehvar

Oct 20, 2023

Invitae has appointed David Sholehvar as chief operating officer, effective Nov. 13. Sholehvar previously served as president of the clinical services division at NeoGenomics and as CEO of Dynex Technologies. He has also held leadership roles at Quest Diagnostics, including as general manager of infectious disease and immunology from 2013 to 2014. He also served as VP for the Americas and EMEA at Ortho Clinical Diagnostics and as general manager of Cellular Technologies, both former Johnson & Johnson companies. While at Cellular Technologies, he oversaw other Johnson & Johnson subsidiaries such as Veridex.

Invitae: David Sholehvar

People in the News at Illumina, Beckman Coulter, Oxford Nanopore, Quanterix, Akoya, Nuclera, More

New Products Posted to GenomeWeb: Sphere Fluidics, Children's Mercy KC, LGC, Genomenon

Editas Medicine Raises $57M by Selling Future Payments From CRISPR Licensing Deal With Vertex Pharma

In Brief This Week: Pacific Biosciences, Macrogen, Dovetail Genomics, Bionano Genomics, More

Exact Sciences Nabs FDA Approval for Cologuard Plus Assay